Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.44
-1.56 (-5.57%)
Jun 20, 2025, 11:59 AM - Market open

Company Description

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms.

The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment.

It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.

The company was founded in 2008 and is headquartered in Irving, Texas.

Caris Life Sciences, Inc.
Country United States
Founded 2008
IPO Date Jun 18, 2025
Industry Biotechnology
Sector Healthcare
Employees 1,769
CEO David Halbert

Contact Details

Address:
750 West John Carpenter Freeway, Suite 800
Irving, Texas 75039
United States
Phone 866 771 8946
Website carislifesciences.com

Stock Details

Ticker Symbol CAI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $21.00
CIK Code 0002019410
CUSIP Number 12477X106
ISIN Number US12477X1063
Employer ID 85-2077369
SIC Code 8071

Key Executives

Name Position
David D. Halbert, D.Sc. (h.c.) Founder, Chairman, and Chief Executive Officer
Brian J. Brille Vice Chairman and Executive Vice President
David Spetzler, M.S., Ph.D., M.B.A. President
Luke Power Senior Vice President, Chief Financial Officer, and Chief Accounting Officer
J. Russel Denton Senior Vice President, General Counsel, and Secretary
George H. Poste, D.V.M., Ph.D., D.Sc., F.R.S. Vice Chairman
Jonathan Knowles, Ph.D. Vice Chairman
Nathan Burns Director
Peter M. Castleman Director
David Fredrickson Director

Latest SEC Filings

Date Type Title
Jun 18, 2025 S-8 Securities to be offered to employees in employee benefit plans
Jun 17, 2025 EFFECT Notice of Effectiveness
Jun 17, 2025 CERT Certification by an exchange approving securities for listing
Jun 16, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jun 13, 2025 8-A12B Registration of securities
Jun 9, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
May 23, 2025 S-1 General form for registration of securities under the Securities Act of 1933
May 8, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Apr 4, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Feb 7, 2025 DRS/A [Amend] [Cover] Draft Registration Statement